Literature DB >> 11679571

Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment.

T Deguchi, S Maeda, M Tamaki, T Yoshida, H Ishiko, M Ito, S Yokoi, Y Takahashi, S Ishihara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679571     DOI: 10.1093/jac/48.5.742

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  20 in total

1.  In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively.

Authors:  D Gruson; S Pereyre; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Authors:  Ryoichi Hamasuna; Yukio Osada; Jørgen Skov Jensen
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Resolution of Symptoms and Resumption of Sex After Diagnosis of Nongonococcal Urethritis Among Men Who Have Sex With Men.

Authors:  Laura C Chambers; James P Hughes; Sara N Glick; Jennifer L Morgan; M Sylvan Lowens; Tashina S Robinson; Sarah S Romano; Gina L Leipertz; Jørgen S Jensen; Christine M Khosropour; David N Fredricks; Matthew R Golden; Lisa E Manhart
Journal:  Sex Transm Dis       Date:  2019-10       Impact factor: 2.830

4.  Clinical evaluation of commercial PCR assays for antimicrobal resistance in Mycoplasma genitalium and estimation of resistance-mediated mutation prevalence in Moscow and Moscow region.

Authors:  Elizaveta Dmitrievna Shedko; Guzel Anvarovna Khayrullina; Elena Nikolaevna Goloveshkina; Vasiliy Gennadevich Akimkin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-30       Impact factor: 3.267

5.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

6.  Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis.

Authors:  Laura C Chambers; Jørgen S Jensen; Jennifer L Morgan; M Sylvan Lowens; Sarah S Romano; Patricia A Totten; Olusegun O Soge; James P Hughes; Matthew R Golden; Lisa E Manhart
Journal:  Sex Transm Dis       Date:  2019-12       Impact factor: 2.830

7.  Levels of Mycoplasma genitalium Antimicrobial Resistance Differ by Both Region and Gender in the State of Queensland, Australia: Implications for Treatment Guidelines.

Authors:  E L Sweeney; E Trembizki; C Bletchly; C S Bradshaw; A Menon; F Francis; J Langton-Lockton; G R Nimmo; D M Whiley
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

8.  Long Duration of Asymptomatic Mycoplasma genitalium Infection After Syndromic Treatment for Nongonococcal Urethritis.

Authors:  Sarah S Romano; Jørgen S Jensen; M Sylvan Lowens; Jennifer L Morgan; Laura C Chambers; Tashina S Robinson; Patricia A Totten; Olusegun O Soge; Matthew R Golden; Lisa E Manhart
Journal:  Clin Infect Dis       Date:  2019-06-18       Impact factor: 9.079

9.  Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.

Authors:  Yuko Yamaguchi; Masaya Takei; Ryuta Kishii; Mitsuru Yasuda; Takashi Deguchi
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

10.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.